Crossmark

Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota

Crossref DOI link: https://doi.org/10.1186/s12866-019-1610-8

Published Online: 2019-11-06

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Chunsaier

Li, Wenbin

Wang, Hongying

Ma, Yiming

Zhao, Xinhua

Zhang, Xudong

Yang, Hong

Qian, Jiaming

Li, Jingnan http://orcid.org/0000-0002-9578-2580
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81370500, 81770559)
License Information

Text and Data Mining valid from 2019-11-06

Version of Record valid from 2019-11-06
More Information

Article History

Received: 15 May 2018

Accepted: 1 October 2019

First Online: 6 November 2019

Ethics approval

: All animal care and experimental procedures in this study were approved by the Animal Care Ethics and Use Committee of Peking Union Medical College (XHDW-2015-0032).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below